Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Celal Acar"'
Autor:
Serife Solmaz, Celal Acar, Ahmet Seyhanlı, Omur Gokmen Sevindik, Ozden Piskin, Mehmet Ali Ozcan, Fatih Demirkan, Bülent Undar, Inci Alacacioglu, Guner Hayri Ozsan
Publikováno v:
Indian Journal of Transplantation, Vol 14, Iss 1, Pp 57-62 (2020)
Introduction: High-dose chemotherapy (HDC) and autologous stem cell transplantation(ASCT) still remains in the treatment of myeloma patients even during the period of new agents. Materials and Methods: We analysed the prognostic affect of pretranspla
Externí odkaz:
https://doaj.org/article/d3fc096c721d4ec1a3550a2022a31539
Autor:
Şerife Solmaz Medeni, Doğus Türkyılmaz, Celal Acar, Ömür Gökmen Sevindik, Faize Yüksel, Özden Pişkin, Mehmet Ali Özcan, Fatih Demirkan, Bülent Ündar, İnci Alacacıoğlu, Güner Hayri Özsan
Publikováno v:
Turkish Journal of Hematology, Vol 35, Iss 4, Pp 271-276 (2018)
Objective: High-doses of melphalan treatment with autologous stem cell transplantation in multiple myeloma (MM) remains a major treatment modality in suitable patients. A minimal dose of 2x106/kg CD34+ cells is preferred to achieve engraftment. Some
Externí odkaz:
https://doaj.org/article/3903f33454c340b9bbc990d2d2e4c0d0
Autor:
Serife Solmaz, Ozcan Uzun, Celal Acar, Omur Gokmen Sevindik, Ozden Piskin, Hayri Guner Ozsan, Fatih Demirkan, Bulent Undar, Ahmet Alacacioglu, Mehmet Ali Ozcan, Inci Alacacioglu
Publikováno v:
Journal of Laboratory Physicians, Vol 10, Iss 04, Pp 363-369 (2018)
BACKGROUND: Recent reports showed neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR), as a predictor of progression-free survival (PFS) and overall survival (OS) in various malignancies. M
Externí odkaz:
https://doaj.org/article/9614468517bc47dc9a3cff5ebe6f7c96
Autor:
Ömür Gökmen Sevindik, İnci Alacacıoğlu, Abdullah Katgı, Şerife Medeni Solmaz, Celal Acar, Özden Pişkin, Mehmet Ali Özcan, Fatih Demirkan, Bülent Ündar, Güner Hayri Özsan
Publikováno v:
Case Reports in Hematology, Vol 2015 (2015)
Transplantation-associated thrombotic microangiopathy (TA-TMA) is a challenge after allogeneic hematopoietic progenitor cell transplantation, considering the diagnostic uncertainties and lack of established treatment. We report a 43-year-old male pat
Externí odkaz:
https://doaj.org/article/6097feba29e24b9cae7ac56646388297
Autor:
Burak TOK, Celal ACAR
Publikováno v:
Troia Medical Journal.
Amaç: Çalışmamızda; hastanemize başvuran hematolojik maligniteli hastaların sıklığının cinsiyet, yaş ve tanıya göre dağılımının saptanması, hastalara eşlik eden kronik hastalıkların, hastaların yaşam sürelerinin ve hayatta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e4138ecf0d028328b25090cfa6433bf
https://doi.org/10.55665/troiamedj.1229528
https://doi.org/10.55665/troiamedj.1229528
Autor:
Ahmet Seyhanli, Bülent Ündar, Celal Acar, Sema Alpçavuş, Ömür Gökmen Sevindik, Feyza Mutlay, Fatih Demirkan, İnci Alacacioğlu, Şerife Solmaz, Mehmet Ali Özcan, Güney Hayri Özsan
Publikováno v:
LLM Dergi. 4:1-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd095023e4483ce2c1303138bbe5746e
https://doi.org/10.5578/llm.69347
https://doi.org/10.5578/llm.69347
Publikováno v:
Uludağ Üniversitesi Tıp Fakültesi Dergisi. 45:5-11
Bu çalışmada; lenfomada ilk basamak tedavi sonrasında Flor-18 fluorodeoksiglukoz pozitron emisyon tomografisinin (FDG-PET/BT) rezidüel SUVmax değerine göre duyarlılık ve özgünlüğünün geriye dönük olarak klinik takip veya biyopsi sonu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de281343e386328b1b20b0b240cab56d
https://doi.org/10.32708/uutfd.464814
https://doi.org/10.32708/uutfd.464814
Autor:
Celal Acar, Mehmet Ali Özcan, Ömür Gökmen Sevindik, Serife Solmaz, Inci Alacacioglu, Bülent Ündar, Fatih Demirkan, Güner Hayri Özsan, Ahmet Seyhanli, Özden Pişkin
Publikováno v:
Indian Journal of Transplantation, Vol 14, Iss 1, Pp 57-62 (2020)
Introduction: High-dose chemotherapy (HDC) and autologous stem cell transplantation(ASCT) still remains in the treatment of myeloma patients even during the period of new agents. Materials and Methods: We analysed the prognostic affect of pretranspla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62cbe2ec9bbcaabd9e9b9daa11e9b521
https://avesis.deu.edu.tr/publication/details/81abe326-73f2-4014-aad7-f6fc9eb3172a/oai
https://avesis.deu.edu.tr/publication/details/81abe326-73f2-4014-aad7-f6fc9eb3172a/oai
Autor:
Bülent Ündar, Şerife Solmaz, Selda Kahraman, Inci Alacacioglu, Celal Acar, Omur Gokmen Sevindik, Munire Turkyilmaz, Hayri Özsan, Mehmet Ali Özcan, Özden Pişkin, Fatih Demirkan
Peripheral blood is the prefered source for hematopoietic stem cells for hematopoietic stem cell transplantation. The efficiency of peripheral blood stem cell (PBSC) collection can vary among devices. In this study we aimed to compare feasibility and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a53f1bf9948368c15f8fc3877f737f5
https://avesis.deu.edu.tr/publication/details/5b2ba4f1-013c-45e7-bea3-a426ba46081d/oai
https://avesis.deu.edu.tr/publication/details/5b2ba4f1-013c-45e7-bea3-a426ba46081d/oai
Autor:
Omur Gokmen Sevindik, Fatih Demirkan, Inci Alacacioglu, Mehmet Ali Özcan, Doğuş Türkyılmaz, Celal Acar, Güner Hayri Özsan, Şerife Solmaz Medeni, Faize Yuksel, Bülent Ündar, Özden Pişkin
Publikováno v:
Turkish Journal of Hematology
Turkish Journal of Hematology, Vol 35, Iss 4, Pp 271-276 (2018)
Turkish Journal of Hematology, Vol 35, Iss 4, Pp 271-276 (2018)
Objective High-doses of melphalan treatment with autologous stem cell transplantation in multiple myeloma (MM) remains a major treatment modality in suitable patients. A minimal dose of 2x106/kg CD34+ cells is preferred to achieve engraftment. Some p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52b657263f8da7ad6bde79178c30a05b
https://pubmed.ncbi.nlm.nih.gov/29923493
https://pubmed.ncbi.nlm.nih.gov/29923493